Economic Value of Lost Productivity Attributable to Human Papillomavirus Cancer Mortality in the United States
- PMID: 33665180
- PMCID: PMC7921151
- DOI: 10.3389/fpubh.2020.624092
Economic Value of Lost Productivity Attributable to Human Papillomavirus Cancer Mortality in the United States
Erratum in
-
Corrigendum: Economic Value of Lost Productivity Attributable to Human Papillomavirus Cancer Mortality in the United States.Front Public Health. 2021 Jul 26;9:691634. doi: 10.3389/fpubh.2021.691634. eCollection 2021. Front Public Health. 2021. PMID: 34381752 Free PMC article.
Abstract
Objectives: To estimate years of potential life lost (YPLL) and present value of future lost productivity (PVFLP) associated with premature mortality due to HPV-attributable cancers, specifically those targeted by nonavalent HPV (9vHPV) vaccination, in the United States (US) before vaccine use. Methods: YPLL was estimated from the reported number of deaths in 2017 due to HPV-related cancers, the proportion attributable to 9vHPV-targeted types, and age- and sex-specific US life expectancy. PVFLP was estimated as the product of YPLL by age- and sex-specific probability of labor force participation, annual wage, value of non-market labor, and fringe benefits markup factor. Results: An estimated 7,085 HPV-attributable cancer deaths occurred in 2017 accounting for 154,954 YPLL, with 5,450 deaths (77%) and 121,226 YPLL (78%) attributable to 9vHPV-targeted types. The estimated PVFLP was $3.3 billion for cancer deaths attributable to 9vHPV-targeted types (86% from women). The highest productivity burden was associated with cervical cancer in women and anal and oropharyngeal cancers in men. Conclusions: HPV-attributable cancer deaths are associated with a substantial economic burden in the US, much of which could be vaccine preventable.
Keywords: cervical cancer; human papillomavirus; mortality; oropharyngeal cancer; productivity loss.
Copyright © 2021 Priyadarshini, Prabhu, Snedecor, Corman, Kuter, Nwankwo, Chirovsky and Myers.
Conflict of interest statement
VP, BK, CN, and DC are employees of Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA, who may own stock and/or hold stock options in Merck & Co., Inc., Kenilworth, NJ, USA. MP, SS, and SC are employees of Pharmerit – an OPEN Health Company, paid consultants to Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, NJ, USA. The remaining author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Figures
References
-
- Centers for Disease Control and Prevention . HPV-Associated Cancer Diagnosis by Age (2019). Available online at: https://www.cdc.gov/cancer/hpv/statistics/age.htm (accessed March 25, 2020).
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
